Literature DB >> 28858385

Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.

Gilton M Fonseca1, Paulo Herman1, Sheila F Faraj2, Jaime A P Kruger1, Fabricio F Coelho1, Vagner B Jeismann1, Ivan Cecconello1, Venancio A F Alves2, Timothy M Pawlik3, Evandro S de Mello2.   

Abstract

Colorectal cancer is a leading cause of death worldwide. The liver is the most common site of distant metastases, and surgery is the only potentially curative treatment, although the recurrence rate following surgery is high. In order to define prognosis after surgery, many histopathological features have been identified in the primary tumour. In turn, pathologists routinely report specific findings to guide oncologists on the decision to recommend adjuvant therapy. In general, the pathological report of resected colorectal liver metastases is limited to confirmation of the malignancy and details regarding the margin status. Most pathological reports of a liver resection for colorectal liver metastasis lack information on other important features that have been reported to be independent prognostic factors. We herein review the evidence to support a more detailed pathological report of the resected liver specimen, with attention to: the number and size of liver metastases; margin size; the presence of lymphatic, vascular, perineural and biliary invasion; mucinous pattern; tumour growth pattern; the presence of a tumour pseudocapsule; and the pathological response to neoadjuvant chemotherapy. In addition, we propose a new protocol for the evaluation of colorectal liver metastasis resection specimens.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  colorectal cancer; liver metastases; liver resection; pathology; prognosis

Mesh:

Year:  2017        PMID: 28858385     DOI: 10.1111/his.13378

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?

Authors:  Vitoria Ramos Jayme; Gilton Marques Fonseca; Isaac Massaud Amim Amaral; Fabricio Ferreira Coelho; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Rafael Soares Nunes Pinheiro; Evandro Sobroza de Mello; Paulo Herman
Journal:  Ann Surg Oncol       Date:  2021-04-08       Impact factor: 5.344

2.  A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.

Authors:  Zhenyuan Zhou; Xin Han; Diandian Sun; Zhiying Liang; Wei Wu; Haixing Ju
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

3.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

4.  Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.

Authors:  Kiichi Sugimoto; Kazuhiro Sakamoto; Yuki Ii; Kota Amemiya; Hiroyuki Sugo; Tomoaki Ito; Shinya Munakata; Makoto Takahashi; Yutaka Kojima; Yuichi Tomiki; Koichi Sato; Akio Saiura; Seiji Kawasaki
Journal:  BMC Surg       Date:  2021-04-09       Impact factor: 2.102

5.  Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.

Authors:  Guoying Zhou; Lisanne Noordam; Dave Sprengers; Michail Doukas; Patrick P C Boor; Adriaan A van Beek; Remco Erkens; Shanta Mancham; Dirk Grünhagen; Anand G Menon; Johan F Lange; Pim J W A Burger; Alexandra Brandt; Boris Galjart; Cornelis Verhoef; Jaap Kwekkeboom; Marco J Bruno
Journal:  Oncoimmunology       Date:  2018-04-25       Impact factor: 8.110

6.  Hepatic changes after treatment with oxaliplatin.

Authors:  Leila Pereira Tenório; Michelle Ferraz Oliveira Miranda; Marcony Queiroz Andrade; Marcelo Antônio Nobrega Araujo
Journal:  Radiol Bras       Date:  2019 Sep-Oct

7.  Surgery improves the prognosis of colon mucinous adenocarcinoma with liver metastases: a SEER-based study.

Authors:  Jia Huang; Guodong Chen; Huan Liu; Yiwei Zhang; Rong Tang; Qiulin Huang; Kai Fu; Xiuda Peng; Shuai Xiao
Journal:  BMC Cancer       Date:  2020-09-23       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.